Section 1 definitions of "aboriginal", "aboriginal midwifery", "midwifery" and "midwifery diagnosis" BEFORE amended by BC Reg 167/2020, effective September 1, 2020.

"aboriginal" means relating to the Indian, Inuit or Métis peoples of Canada;

"aboriginal midwifery" means

(a) traditional aboriginal midwifery practices including the use and administration of traditional herbs and medicines and other cultural and spiritual practices,

(b) contemporary aboriginal midwifery practices which are based on, or originate in, traditional aboriginal midwifery practices, or

(c) a combination of traditional and contemporary aboriginal midwifery practices;

"midwifery" means the health profession in which a person provides the following services during normal pregnancy, labour, delivery and the post-partum period:

(a) assessment, monitoring and care for women, newborns and infants, including the carrying out of appropriate emergency measures when necessary;

(b) counselling, supporting and advising women, including provision of advice and information regarding care for newborns and infants;

(c) conducting internal examinations of women, performing episiotomies and amniotomies and repairing episiotomies and simple lacerations;

(d) contraceptive services for women during the 3 months following a birth;

"midwifery diagnosis" means a clinical judgment of a woman's mental or physical condition, or that of her newborn, to determine whether

 Section 1 definitions of "patient" and "registrant" were added by BC Reg 167/2020, effective September 1, 2020.

 Section 2 BEFORE re-enacted by BC Reg 167/2020, effective September 1, 2020.

 Section 4 (2) BEFORE amended by BC Reg 167/2020, effective September 1, 2020.

(2) An aboriginal registrant may practise aboriginal midwifery.

 Section 4.1 was enacted by BC Reg 167/2020, effective September 1, 2020.

 Section 5 (k) and (l) BEFORE amended by BC Reg 274/2016, effective November 24, 2016.

(k) in respect of a drug specified in Schedule I or IA of the Drug Schedules Regulation or a barbiturate, narcotic or targeted substance, if the drug, barbiturate, narcotic or targeted substance is prescribed by a medical practitioner,

(i) compound the drug, barbiturate, narcotic or targeted substance,

(ii) dispense the drug, barbiturate, narcotic or targeted substance, or

(iii) administer the drug, barbiturate, narcotic or targeted substance by any method;

(l) in respect of a drug specified in Schedule I of the Drug Schedules Regulation, if included in a category described in Schedule A or B to this regulation,

(i) prescribe the drug,

(ii) compound the drug,

(iii) dispense the drug, or

(iv) administer the drug by any method;

 Section 5 (1) (c) and (e) BEFORE amended by BC Reg 167/2020, effective September 1, 2020.

(c) insert acupuncture needles under the skin for the purpose of pain relief during labour or the post-partum period;

(e) for the purpose of wound care during the post-partum period, administer a solution by irrigation;

 Section 5 (1) (g) (iii) BEFORE amended by BC Reg 167/2020, effective September 1, 2020.

(iii) beyond the opening of the urethra, for the purpose of catheterization of a woman during labour or the post-partum period,

 Section 5 (1) (g) (iv) (A) BEFORE amended by BC Reg 167/2020, effective September 1, 2020.

(A) conducting internal examinations of women,

 Section 5 (2) BEFORE amended by BC Reg 167/2020, effective September 1, 2020.

(2) Subsection (1.1) does not apply on a reserve to an aboriginal person who practised aboriginal midwifery prior to March 15, 1995.

 Section 6 (2), (3), (4) and (5) BEFORE amended by BC Reg 274/2016, effective November 24, 2016.

(2) A registrant may provide a service that includes the performance of an activity described in section 5 (1) (c), (g) (iv) (D) or (g) (vi) only if the registrant has successfully completed a certification program established, required or approved under the bylaws to ensure registrants are qualified and competent to provide the service and perform the activity.

(3) A registrant may perform an activity described in 5 (1) (k) only after consulting with a medical practitioner, unless the registrant is authorized under section 5 (1) (l) and subsections (4) and (5) of this section to perform the activity.

(4) A registrant may perform an activity described in 5 (1) (l) in respect of a drug included in a category of drugs set out in

(a) Column 1 of Schedule A, only for a purpose shown opposite in Column 2 of Schedule A, and

(b) Column 1 of Schedule B, only for a purpose shown opposite in Column 2 of Schedule B.

(5) A registrant may perform an activity described in section 5 (1) (l) under subsection (4) (b) only if the registrant has successfully completed a certification program established, required or approved under the bylaws to ensure registrants are qualified and competent to provide the service and perform the activity.

 Section 6 (1) and (6) BEFORE amended by BC Reg 167/2020, effective September 1, 2020.

(1) A registrant must consult with a medical practitioner or nurse practitioner regarding any deviations from the normal course of pregnancy, labour, delivery and the post-partum period that indicate pathology and transfer responsibility for care to another health professional when necessary or appropriate.

(6) A registrant may perform an activity described in section 5 (1) (k) to (m) only in respect of a woman or her newborn, as the case may be, during pregnancy, labour, delivery or the post-partum period.

 Schedule A, items "Anti-coagulants", "Benzodiazepines" and "Narcotics" were added by BC Reg 274/2016, effective November 24, 2016.